- Report
- August 2024
- 150 Pages
Global
From €4739EUR$4,850USD£3,956GBP
- Report
- July 2024
Global
From €4739EUR$4,850USD£3,956GBP
- Report
- March 2024
- 150 Pages
Global
From €4739EUR$4,850USD£3,956GBP
- Report
- January 2024
- 150 Pages
Global
From €4739EUR$4,850USD£3,956GBP
- Report
- August 2024
- 136 Pages
Global
From €3810EUR$3,899USD£3,180GBP
- Report
- May 2024
- 138 Pages
Global
From €6350EUR$6,499USD£5,301GBP
- Report
- July 2024
- 115 Pages
Global
From €4641EUR$4,750USD£3,874GBP
- Report
- February 2024
- 110 Pages
Global
From €4641EUR$4,750USD£3,874GBP
- Clinical Trials
- August 2024
- 60 Pages
Global
From €855EUR$875USD£714GBP
€1221EUR$1,250USD£1,020GBP
- Report
- June 2024
- 200 Pages
Global
From €5437EUR$5,565USD£4,539GBP
€7768EUR$7,950USD£6,485GBP
- Report
- June 2024
- 200 Pages
Global
From €5437EUR$5,565USD£4,539GBP
€7768EUR$7,950USD£6,485GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1368EUR$1,400USD£1,142GBP
€1954EUR$2,000USD£1,631GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1368EUR$1,400USD£1,142GBP
€1954EUR$2,000USD£1,631GBP
- Report
- May 2024
- 182 Pages
Global
From €4397EUR$4,500USD£3,671GBP
- Report
- August 2024
- 178 Pages
Global
From €2443EUR$2,500USD£2,039GBP
- Report
- December 2023
- 162 Pages
Global
From €2443EUR$2,500USD£2,039GBP
- Drug Pipelines
- August 2024
- 150 Pages
Global
From €2442EUR$2,499USD£2,038GBP
- Report
- April 2024
- 140 Pages
Global
From €4884EUR$4,999USD£4,078GBP
- Report
- April 2024
- 92 Pages
Global
From €3500EUR$3,837USD£3,024GBP
- Report
- April 2024
- 108 Pages
Global
From €3500EUR$3,837USD£3,024GBP
The Cough and Cold Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of medications used to treat symptoms of the common cold and other respiratory illnesses. These drugs are typically available over-the-counter and are used to reduce the severity of symptoms such as coughing, sneezing, sore throat, and congestion. Common ingredients in these medications include decongestants, antihistamines, expectorants, and pain relievers.
The Cough and Cold Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in this market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Novartis, and Sanofi. These companies have a wide range of products available, from traditional medications to more innovative treatments. Additionally, many smaller companies are also active in this market, offering more specialized products. Show Less Read more